Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
about
Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy.In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study.Seizure prognosis in brain tumors: new insights and evidence-based managementPharmacokinetic interactions with antiepileptic drugs: always the bad actor or simply misunderstood?Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.Risk factors for seizures and antiepileptic drug-associated adverse effects in high-grade glioma patients: A multicentre, retrospective study in Hong KongBrain tumor-related epilepsy.Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.Seizures in low- and high-grade gliomas: current management and future outlook.Epilepsy in the cancer patient.Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment.Placebo-corrected efficacy of modern nonenzyme-inducing AEDs for refractory focal epilepsy: systematic review and meta-analysis.Patients with brain tumor-related epilepsy.Why dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma.Enzyme induction with antiepileptic drugs: cause for concern?Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment.Optimizing antiepileptic drug treatment in tumoral epilepsy.Treatment of epileptic seizures in brain tumors: a critical review.Erlotinib: early clinical development in brain cancer.Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics.Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.Does the choice of antiepileptic drug affect survival in glioblastoma patients?Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma.Prognostic relevance of epilepsy at presentation in glioblastoma patientsSurvival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.Anti-convulsants and gene expression in malignant gliomas.Effect of valproic acid on the outcome of glioblastoma multiforme.Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.Does the choice of antiepileptic drug have an impact on the survival of glioblastoma multiforme?Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study.Lecture: profile of risks and benefits of new antiepileptic drugs in brain tumor-related epilepsy.Does valproic acid affect tumor growth and improve survival in glioblastomas?
P2860
Q33400189-CFCB21E2-3A01-4A6E-8A3E-98458022FCF4Q33768138-D95D0724-1429-4C58-AB45-F1AB2ADB2971Q33828100-AF907E7B-7BA1-449C-ADEF-3686762988FAQ33829789-753C77A7-492D-469F-89BE-F95BB75837DEQ34183961-1AB70CDC-C636-4EA7-94FC-F99E5445B9F8Q35691532-CF3C0652-ACD6-4E16-B58C-0B3B9EF9FA6BQ35741951-A6014725-6D67-4984-9453-8D9FA7A5DDBEQ36067319-439DFE03-EAC0-45C1-8655-B53D9D5E3942Q36113188-424EF5AF-0507-46D4-A7B2-79CFB3DF7BB7Q37350851-2E1BD12E-1461-429E-9FE6-76E4C12234E4Q37752365-9493448C-850A-4672-A73D-815434F28922Q37838314-EAEDD542-6DB9-4D82-91E1-AC13931FC02AQ37968607-1E565C64-D3E6-4B10-BC6B-572CC513BFEEQ37975526-A5AB9042-6CFE-4BD5-ACE3-765AA8B35B2DQ38005050-0EACD14E-F9F7-4B61-AC56-B3A4FD93F5D4Q38007011-345AF2F4-5C0E-4C2E-891C-CEF7ED4DFABCQ38046892-DA8FA831-AAE8-4578-BC4D-BCF44CF4329AQ38105151-9949907C-F841-4AE3-A6B5-0CD887C89077Q38170433-2C5C6159-6152-4707-BD2B-15DEBF501129Q38206723-AC4B2DD9-5A18-4360-8632-FF67C8EB60D2Q38212394-7342F46C-E34B-4899-AF81-924BE53D93ABQ38495389-6AB7FF7E-9896-4CDB-B4F5-E30E61E78D9FQ38587724-CE06E1E1-884D-4864-9AC7-66D08E36FA1AQ39632687-B966EE7C-8450-4355-AD4A-30798DE0B973Q39789775-474CF73D-4622-482B-A415-F8821C6E4712Q40016347-1C2C090F-9075-4FAA-949A-96DECF29B4CFQ41738194-A73C1CB1-1C53-40D8-9302-BB4EA366AFE4Q42792502-8CFF9D1C-66E1-4AE1-BD97-3A4FCB58165EQ45231801-9C79CEAD-9594-48A6-A1BE-016E4ADBCBE0Q47949323-D9868A86-5ED7-430C-A181-9900751C886AQ48134397-AFC6015D-061A-4B4F-BCE4-25F77EAE0740Q48187820-F2E4DDF4-B922-42D0-B679-520C09F133F5Q48536808-7D3C34D7-BB91-41D2-AE53-6F913CDD34ECQ48827723-1F5F5429-9468-4075-83B0-4260FEDFC7E3
P2860
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Correlation of enzyme-inducing ...... of patients with glioblastoma.
@en
Correlation of enzyme-inducing ...... of patients with glioblastoma.
@nl
type
label
Correlation of enzyme-inducing ...... of patients with glioblastoma.
@en
Correlation of enzyme-inducing ...... of patients with glioblastoma.
@nl
prefLabel
Correlation of enzyme-inducing ...... of patients with glioblastoma.
@en
Correlation of enzyme-inducing ...... of patients with glioblastoma.
@nl
P2093
P2860
P1433
P1476
Correlation of enzyme-inducing ...... of patients with glioblastoma.
@en
P2093
Alfred Furth
Jan C Buckner
Karla Ballman
Kurt A Jaeckle
P2860
P304
P356
10.1212/WNL.0B013E3181BBFECA
P407
P577
2009-10-01T00:00:00Z